ArticleBMC cancer2026
Catastrophic health expenditure and its determinant factors among patients with cancer attending Wolaita Sodo University Comprehensive Specialized Hospital, South Ethiopia.
Article in BMC cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCancer patients often face catastrophic health expenditures (CHE), leading to significant financial burdens for households. When cancer treatment depends mainly on out-of-pocket payments, the risk of incurring CHE increases; thus, this study assessed the incidence and key factors contributing to CHE among cancer patients.
methodsA cross-sectional study was conducted at Wolaita Sodo University Comprehensive Specialized Hospital, including 294 cancer patients selected systematically. Data were analyzed using SPSS version 27, with bivariable and multivariable logistic regression models used to assess associations between CHE and independent variables.
resultsAmong cancer patients, the incidence of catastrophic health expenditure (CHE) at a 40% threshold was 83.7% (95% CI: 78.9-87.4). Medication cost constituted the largest treatment expense, accounting for 66.7% of total costs. Multivariable analysis identified three independent factors significantly associated with CHE: lack of formal education (AOR = 3.6; 95% CI: 1.1-12.0), absence of health insurance (AOR = 3.2; 95% CI: 1.5-7.0), and cancer diagnosis in private facilities (AOR = 4.2; 95% CI: 3.5-13.7).
conclusionThe incidence of catastrophic health expenditure (CHE) was higher than reported in published studies. Key contributing factors included lack of insurance, educational status, and diagnosis at private healthcare facilities, all of which exacerbated financial hardship. Expanding community-based health insurance (CBHI) is essential, especially for low-income households. Furthermore, hospitals should enhance access to cancer diagnostic services to help alleviate the financial burden of diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.